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Fc  receptors  (FcR) 1,  membrane  glycoproteins which  bind  Ig  molecules via 
their Fc region, have been identified (1) on the surface of various cell types. For 
example,  FcR  for  IgG are  expressed on  macrophages, B  and T  lymphocytes, 
cytotoxic T  lymphocytes, and natural killer cells. FcR are important in immune 
regulation,  and  several  studies  have  addressed  their  role  in  isotype-specific 
responses.  In  this regard,  T  lymphocyte subpopulations have  been  described 
with FcR for IgM (FcttR) (2), XgD (Fc6R) (3), IgG (Fc~,R) (4), IgE (Fc~R) (5), and 
IgA (FcaR) (6). Previous studies (1, 7, 8) have shown that FcyR-bearing (Fc-yR +) 
T  cells and T  cell hybridomas regulate IgG production. These T  cells release 
Fc~,R molecules, termed IgG-binding factors (IBF~) that suppress IgG synthesis 
(7, 8). Others (9-12) have demonstrated that IgE-binding factors (IBFe) released 
from FceR  + T  lymphocytes regulate IgE immune responses. IBFt possess opposite 
regulatory functions; one factor specifically enhances the IgE response, while a 
second factor suppresses this isotype (10,  11).  Both IgE-potentiating factor and 
IgE-suppressive factor are produced by the same FctR  + T  cell subpopulation (9, 
12). 
T  lymphocytes bearing FcaR have been described (6, 13) in both humans and 
mice.  FcaR +  T  cells  appear  to  be  involved  in  regulation,  because  increased 
numbers of FcaR  + T  lymphocytes of a suppressor phenotype have been isolated 
from mice with IgA myeloma (14), and have been shown (15) to suppress IgA 
isotype-specific  responses.  Others  (16,  17)  have  reported  that  FcaR  + T  cell 
hybridomas, or concanavalin A (Con A)-activated FcolR  + T  cells, incubated with 
IgA,  release  IBFt~  that  can  suppress  IgA  production  in  pokeweed  mitogen- 
stimulated  spleen  cell  cultures.  On  the  other  hand,  FcaR +  T  lymphocytes 
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separated  from  human peripheral  blood  have  been  shown  (18)  to  specifically 
enhance IgA responses in pokeweed mitogen-driven B cell cultures. 
Our previous studies (19, 20) have shown that oral immunization of mice with 
the T  cell-dependent antigen, sheep red blood cells (SRBC), induces significant 
T  helper (Th) cell activity in Peyer's patches (PP), and that this T  cell population 
preferentially supports IgA immune responses both in vitro and in vivo. Subse- 
quently, (21, 22) we have isolated and characterized Th cell clones from murine 
PP that express  FcaR on their surface, and which largely support in vitro IgA 
responses (PP Th A cells). The preferential help for IgA responses was found to 
be  mediated by collaboration between FcaR  + PP Th A  cells and mature,  IgA- 
committed B cells (22). On the other hand, T  cell clones have been isolated from 
murine PP that appear  to induce switching of surface IgM-positive (sIgM  +) B 
cells to those expressing surface IgA (sIgA  +) (23, 24). 
In the present study, we have developed T-T  hybridomas by fusing PP Th A 
cells with R 1.1 T  lymphoma cells to examine the molecular mechanisms involved 
in Th-B cell collaboration for IgA isotype-specific responses. These hybridomas 
have  been  maintained  in  fetal  calf serum  (FCS)-free  medium.  A  number  of 
hybridomas express  FcaR,  and supernatants  from these cells regulate in  vitro 
IgA responses.  Characterization  of these  hybridomas and their released  IBFa 
are  discussed  from  the  standpoint  of their  role  in  selection,  triggering,  and 
regulation of committed sIgA  + B cells for IgA isotype synthesis. 
Materials and Methods 
T Cell Lines.  PP Th A cells (Thy-l.2  ÷, Lyt-1 +, FcaR  +, and H-2  k) were derived from 
PP of C3H/HeJ (H-2 k) mice, as previously described (21, 22). Two types of PP Th A cells 
were used for the production ofT-T hybridomas: PP Th A clone 1 showed some support 
for IgM responses, in addition to its strong support of IgA responses;  PP Th A clone 9 
showed  low-level  support  for  IgM  and  for  IgG  subclasses,  and  greatly elevated  IgA 
responses (21). The R1.1  T  iymphoma cell line used for cell fusion expresses Thy-l.2, 
TL, and H-2  k (25,  26) and was kindly provided by Dr. J.  F.  Kearney (Department of 
Microbiology, University of Alabama at Birmingham). 
Formation of T-T Hybridomas.  For the generation of hybridomas, PP Th A clones 1 or 
9 were fused with R 1.1 T lymphoma cells using polyethylene glycol, tool wt 4,000 (Sigma 
Chemical Co., St.  Louis,  MO),  as previously described (8,  27,  28).  Equal  numbers of 
PP Th A cells and RI.1 cells were pelleted together and fused by adding 1 ml of 50% 
polyethylene glycol in RPMI  1640 (Gibco Laboratories, Grand Island, NY). After 1 min 
of incubation at 37°C, the cell suspension was gradually diluted to 10 ml with RPMI 1640 
over a  5 min interval. The cells were washed by centrifugation (1,000  rpm) in RPMI 
1640.  After washing, cells were resuspended in medium consisting of complete medium 
(RPMI  1640  supplemented with  2  mM t.-glutamine,  100  U/ml  penicillin,  100  ~g/ml 
streptomycin, 5 ×  10  -5 M 2-mercaptoethanol and 10% FCS)with 0.01  M hypoxanthine, 
4 ×  10  -7 M aminopterin, and 1.6 ×  10  -6 M thymidine (28). After 3-4 wk of growth in 
selective medium, it was gradually removed and replaced by complete medium. 
After growth of hybrid cells in complete medium (3-4 wk), culture supernatants were 
screened by the in vitro plaque-forming cell (PFC) assay (see below). Briefly, supernatant 
fluids were  added  to  lipopolysaccharide (LPS)-stimulated splenic  B  cell  cultures,  and 
immunized with SRBC. After 5 d of incubation, cells were harvested and tested for IgA 
anti-SRBC PFC responses.  Individual wells of hybridomas that produced factors for the 
enhancement of in  vitro IgA immune responses  were subcloned by limiting dilution. 
Selected subclones were expanded and maintained in  culture with complete medium. 
Additional sets  of selected  subclones  were  gradually adapted  to  growth  in  FCS-free 
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of 50% HB  102 and 50% complete medium, then in 90%  HB 102 and  10%  complete 
medium before being shifted to FCS-free medium. 
Characterization of T-T Hybridomas.  Cell suspensions (1-2 x  106 cells) were incubated 
(45 min, 4°C) with 20 ~tl of fluorescein isothiocyanate (FITC)-Iabeled anti-Thy-l.2 (clone 
30 H-12), anti-Lyt-I (clone 53-7.313), anti-Lyt-2 (clone 53-6-72), or anti-I-A  k (clone 11- 
5.2) monoclonal antibody (mAb). The cells were then washed three times with phosphate- 
buffered saline (PBS) containing 1% FCS. The proportion of cells that stained with FITC- 
labeled reagent was determined by counting ~> 1,000 cells using a fluorescence microscope 
(Orthoplan, Leitz, Inc., Wetzlar, Federal Republic of Germany). 
An immunocytoadherence assay was performed for assessment of surface Fc receptors 
on T-T hybridomas. Trinitrophenyl (TNP)-sensitized SRBC were prepared as previously 
described (21,  29).  MOPC 315 IgA against dinitrophenyl (DNP) was purified by DNP 
affinity chromatography (30).  IgM (H5-3) and IgGl (H35-3) anti-DNP mAb were kindly 
provided  by J.  O.  Phillips  (Department  of Microbiology,  University  of Alabama  at 
Birmingham). Hybridoma cells (4  ×  106 celis/ml) were treated with  100-200 #g/ml of 
anti-DNP mAb for 1 h at 37°C, then washed three times with RPMI 1640 containing 2% 
FCS.  The  mAb-treated  cells  were  mixed  with  a  0.5%  suspension  of TNP-SRBC and 
incubated for 30 min at 4°C.  Rosette-forming cells were scored by the immunocytoad- 
herence assay (21). 
Splenic and PP Cell Preparations.  Spleens and PP were aseptically removed from 
C3H/HeN (H-2  k) mice that were either left untreated, or were orally primed with SRBC. 
Single cell suspensions were prepared as previously described (19, 20). Spleen cells were 
gently passed through sterile stainless  steel screens into the appropriate media. Cells from 
PP were obtained by disassociating the tissue with the enzyme Dispase  in Joklik-modified 
medium (Gibco Laboratories) (19, 20). 
Preparation  of B  and  T  Lymphocytes, and  Accessory Cells.  Splenic  or  PP  single-cell 
suspensions from normal mice were treated with a  cocktail of anti-T cell mAb (anti- 
mouse Thy-l.2 [clone H0-13-4], anti-Lyt-1 [clone 53-7.313], and anti-Lyt-2 [clone 53-6- 
72]) as described previously (20,  22).  Cells  were washed in  minimal essential medium 
(Gibco Laboratories) supplemented with L-glutamine, gentamicin, sodium bicarbonate, 
sodium pyruvate, and nonessential amino acids (incomplete medium), and resuspended in 
complete medium (incomplete minimum essential medium plus 10% FCS and 2-mercap- 
toethanol) (20,  21).  In these experiments, it was first necessary to incubate spleen cells 
with phenol/water-extracted LPS, 50/zg]5 x  106 cells/ml for 18 h. The B cell population 
was then prepared by treatment of the nonadberent cells with anti-T cell mAb cocktail, 
followed by a  Ficoll-Hypaque gradient  separation.  These LPS-pretreated B cells  were 
added to macrocuiture plates that contained adherent accessory cells. For preparation of 
adherent cells, spleen cells were treated with the anti-T cell cocktail, followed by 3,000 
rad  irradiation  (Gamma  Cell  1000;  Atomic Energy of Canada  Ltd.,  Kanata,  Ontario, 
Canada).  Cells  were added to macroculture plates, and, after 2 h  incubation at  37°C, 
nonadherent cells were removed by aspiration, and individual wells were washed three to 
five times to completely remove nonadherent cells.  Th cell-enriched (Lyt-I  +) fractions 
were prepared by passing PP cells from SRBC-primed mice through nylon wool columns 
(20). The eluted cells were then treated with anti-mouse Ig serum (Meloy Laboratories 
Inc., Springfield, VA), and anti-Lyt-2 as previously described (20, 22). 
Purification oflBFa.  To purify IBF from T-T hybridoma supernatants and determine 
their isotype specificity, Sepharose 4-B columns,  conjugated with purified monoclonal 
IgM (H5-3), IgG 1 (H35-3), or IgA (MOPC 315) were used. Hybridoma supernatants (35- 
40 ml) from cells grown in FCS-free, HB 102 media were passed over these columns, and 
the  effluent collected and  concentrated  by  negative-pressure  dialysis  to  the  original 
volume. IBF fractions were obtained by elution with glycine-HCl (pH 2.8) buffer into an 
equal volume of borate-saline (pH 8.2) buffer (eluate). The eluate was concentrated to 1- 
3 ml by negative-pressure dialysis against RPMI 1640. The effluent and eluate were tested 
for their ability to enhance or suppress IgA responses in appropriate cultures containing 
antigen, as described below. 
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of culture supernatants or column-purified IBFce from T-T  hybridomas were added to 
macroculture plates (Linbro Chemical  Co.,  Hamden, CT) and immunized witb  SRBC, 
horse red blood cells (HRBC), or TNP-SRBC.  Cultures were incubated at 37°C  in an 
atmosphere of 7% O~, 10% CO2, and 83% N2 (19-22). To examine the regulatory effects 
of IBFc~ on  IgA responses,  PP cell cultures  (2.5  X  10 6) from SRBC-primed mice were 
immunized with  SRBC  in  the presence of different concentrations  of column-purified 
I BFc~. I n addition, these I BFa were tested with cultures containing purified Lyt-1 ÷ T cells 
(10 ~ cells/culture) from PP of orally SRBC-primed mice, and normal splenic B cells (2.5 
x  10  ~ cells/culture) in the presence of SRBC. 
PFC Assay.  After 5 d of culture, nonadherent cells were removed from macroculture 
wells by vigorous pipetting, and washed in Hanks' balanced salt solution (Gibco Labora- 
tories) and resuspended in  Hank's at appropriate dilutions for PFC assay. Cultures were 
assessed for direct (IgM) and indirect (IgG and IgA) anti-SRBC, -HRBC, or -TNP PFC 
responses as previously described (19, 21). 
Measurement of Murine IgM, IgG, and IgA by Radioimmunoassay.  Synthesis of IgM, IgG, 
or lgA in splenic or PP B cell cultures treated with various hybridoma supernatants were 
measured after 5 or 7 d of culture, as previously described (31, 32).  Briefly, polystyrene 
wells (Micro-ELISA, Dynatech Laboratories, Inc., Alexandria, VA) were coated with IgG 
fractions of either  rabbit  anti-mouse #,  ~y, or  a  diluted  in  PBS,  pH  7.2.  Wells were 
aspirated, and protein-binding sites were blocked with 1% bovine serum albumin (radioim- 
munoassay grade,  Sigma Chemical Co.) in  PBS.  Standards of IgM (MOPC  104E),  IgG 
(affinity-purified mouse serum  IgG) (Cappel  Laboratories, Cochranville,  PA),  and  IgA 
(MOPC 315),  over a range of 0.25-25  ng/well, and dilutions of test supernatants were 
incubated in  coated wells  for  16 h  at 25°C.  After washing three times with  PBS,  1251- 
labeled anti-v, -3', or -a was added  to appropriate wells,  and incubated overnight. The 
unbound radioactivity was removed by extensive washing with PBS, and individual wells 
were counted in a gamma counter (Beckman Instruments, Inc., Palo Alto, CA). The IgM, 
IgG, and IgA levels present in cell culture supernatants were determined by reference to 
standard curves generated for each experiment. 
Statistics.  Values for PFC assay are expressed as the mean PFC response per culture 
_+SEM. Rosette formation is expressed as the range per triplicate determinations.  The 
significances of differences between  means of PFC  responses were determined  by the 
student's t-test. 
Results 
Characteristics  of  T-T  Hybridomas  and  Supernatants  Derived  From  PP Th A 
Clones.  PP Th A  clones  1 and 9  were separately fused with  RI.1  T  lymphoma 
cells, or with hybridomas produced in selective medium. Cells from each culture 
well showing hybridoma growth were tested for their ability to support in vitro 
IgA responses.  Positive cultures  were subcloned by limiting dilution.  A  total of 
85  cloned cell lines were derived for subsequent characterization.  Of this total, 
66 hybridomas were obtained from the  PP Th A  clone  1 fusion, and  19 hybri- 
doma lines were established  from PP Th A  clone 9.  These cell lines have been 
designated Th HA to indicate that they are hybridomas derived from T  helper 
cell clones that promote IgA responses.  Culture  supernatants  from each of the 
85 cell lines were tested for their ability to support IgA responses against SRBC 
in splenic B cell cultures from C3H/HeN  (H-2  k) mice. In preliminary studies, we 
found that B cell cultures triggered with LPS (see Materials and Methods) were 
required to detect IgA responses with some culture supernatants. 
Of the  85  hybridoma supernatants  tested,  16 supported  IgA anti-SRBC  PFC 
responses (Table  I).  13  of these were derived from PP Th A  1, and three  were 
from  fusions of PP Th A  clone 9  (Table  I).  Our  previous studies  (21,  22)  had KIYONO  ET  AL.  735 
TABLE  I 
Supernatants from FcctR  ÷ Th HA Support In Vitro IgA Responses in LPS- 
driven B Cell Cultures 
Supernatant source 
Anti-SRBC PFC per culture* 
IgM  IgG  IgA 
Fc~R + 
Th HAl* 
1  339 ± 43  0  345 ±  32 
2  215 ±  16  79 ±  19  548 ± 43 
3  220±24  115± 10  460±52 
4  273 ±  30  0  534 ± 47 
5  393 ± 21  0  466 ± 23 
6  323 ± 52  52 -  9  382 ± 36 
7  224 ± 61  35 ± 4  538 ± 62 
8  426 ±  39  73 +  15  562 ± 35 
9  234±34  116± 11  514±44 
10  251 ±  17  56 ± 9  562 ± 40 
11  319 ± 43  0  557 ± 59 
12  434 ± 28  0  347 ± 66 
13  399 ± 41  0  390 ± 52 
Th HA0 
14  225 + 20  0  515 ± 23 
FcotR- 
Th HA1 
30  328±41  0  11±3 
37  243± 19  2±2  6±3 
42  308±21  3+ 1  12+5 
51  279 ±  37  0  7 ± 2 
Th HA0 
70  288 ± 22  0  9 ± 4 
RI.1  147+31  2+  1  3+  1 
None  154+22  3±2  2+ 1 
Spleen  cells  were  cultured  with  LPS  (phenol/water-extracted)  (5  ×  106 
cells/50 t~g LPS/ml) for 18 h. Nonadherent cells were then treated with anti- 
T  cell mAb cocktail  and rabbit complement, and cultured (2.5  ×  10  ~ cells] 
well) with SRBC (1-2 ×  l0  s) in the presence of adherent cells (macrophages) 
and  supernatants  from Th HA.  PFC responses  were assessed on  day  5  of 
culture. 
* Values  are the mean anti-SRBC  PFC per culture from triplicate  culture for 
each experiment, for three separate  experiments. 
* Subscript  refers to PP Th A parent cell origin. 
shown  that  PP Th  A  clone  1  supports  some  IgM  responses,  and  elevated  IgA 
responses,  while  clone  9  supports  low  IgM,  IgG1,  IgG2,  and  IgG3  responses, 
and high IgA responses.  A  total of 7  of 13  hybridomas from clone  1 supported 
some IgG responses, and one of three hybridoma supernatants from clone 9 gave 
IgG  responses  (Table  I).  However,  the  RI.1  supernatant  did  not  support  the 
IgG  isotype  in  LPS-triggered  cultures.  Although  the  reason  for  these  IgG 
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well  known  that  LPS induces polyclonal responses  among the  IgG subclasses. 
This possibility is further supported by lack of IgG PFC responses in normal PP 
B  cell cultures treated with  Th HA supernatants  (see below).  In  these studies, 
SRBC immunization of LPS-triggered splenic B cells, in the absence of hybridoma 
supernatants, resulted mainly in IgM anti-SRBC PFC responses (Table I). Culture 
supernatants from non-IgA-supporting hybridomas did not induce either IgG or 
IgA isotype responses, although these fractions generally enhanced the in vitro 
IgM PFC response (Table I). Both of the original clones (PP Th A  1 and 9) were 
Thy-1.2  +, and Lyt-1 +,2- and did not express I-A  k (21). All 16 hybridomas which 
produced soluble  factors that  supported  IgA responses expressed the Thy-l.2 
antigen  but  were  Lyt-l-,2-.  66  out  of 69  of the  remaining  hybridomas  also 
exhibited  this  pattern  of surface antigen  expression,  while  3  of 69  were  Thy- 
1.2 +, Lyt-1 +,2 -. 
All  16  hybridomas whose supernatants  support IgA responses to SRBC bear 
Fc receptors  for  IgA  (FcaR  +) (Table II).  On  the  other hand,  none of the  69 
hybridoma lines whose supernatants  failed to support IgA responses expressed 
FcaR. No immunocytoadherence was seen when the 16 hybridomas were treated 
with  either  IgM  or  IgG  anti-TNP  mAb  followed  by  incubation  with  TNP- 
TABLE  II 
Isotype of FcR Present on Th HA 
FcR isotype-specificity  (rosette 
Hybridoma clone  formation)* 
FcaR 
Th HAl*  % 
1  53-76 
2  68-81 
3  59-68 
4  34-47 
5  51-70 
6  66-74 
7  55-62 
8  28-41 
9  30-45 
10  56-71 
11  82-94 
12  60-72 
13  51-66 
Th HA9 
14  85-94 
15  36-46 
16  30-44 
Th HA hybridomas were reacted with either IgM (H5-3), IgG1 (H35- 
3), or IgA (MOPC 315) anti-DNP mAb for 1 h at 37°C. Hybridoma 
cells binding more than five  red cells were counted as positive. Rosettes 
were counted in 10-15 fields. ~>1,000 Th HA cells were scored on each 
slide for each experiment. 
* Rosette formation is expressed as percentage and the range of triplicate 
determinations are presented. No Fc~R- or Fc3,R-bearing hybridomas 
were found. 
* Subscript refers to PP Th A parent cell origin. K1YONO  ET  AL.  737 
conjugated SRBC,  indicating that  these  hybridomas express neither Fc#R  or 
Fc~,R  (Table  II).  To verify this,  each hybridoma cell line was incubated with 
purified MOPC 315  IgA, washed, and stained with rabbit F(ab')2 FITC-labeled 
anti-mouse a, and subjected to flow cytometry. All 16 hybridomas gave strong 
positive staining, confirming the presence of FcaR on their surface. None of the 
hybridomas exhibited immunofluorescence when treated with purified IgM or 
IgG1 and FITC-F(ab')2 anti-heavy chain, and analyzed on a FACS. 
B Cell and Antigen Requirements  for Th HA Hybridoma Supernatant Support of 
IgA Responses.  Since PP Th A clones are SRBC-specific and require antigen for 
in vitro IgA responses, we next determined whether Th HA hybridomas produce 
an antigen-specific, IgA-promoting factor, or whether the supernatants all sup- 
port antigen-induced responses. As summarized in Table III, supernatants from 
eight Th HAl hybridomas, and Th HA9-14 all support SRBC, HRBC, or TNP- 
specific IgA  PFC  responses  in  LPS-triggered splenic B  cell cultures.  The  re- 
sponses were specific for the antigen used in culture, no polyclonal PFC were 
seen. No significant IgA PFC responses occurred in B cell cultures containing 
Th HA supernatants in the absence of antigen (Table III). This shows that IgA 
PFC responses require T-dependent antigen for Th HA supernatant support of 
IgA responses. 
Murine PP contain a significant population of sIgA  + cells, and enrichment of 
this cell type results in higher IgA responses in the presence of PP Th A  cells 
(22).  When  soluble  Th HA  factors  were  added  to  PP  B  cell  cultures  and 
immunized  with  T-dependent  antigens,  good  IgA  PFC  responses  to  SRBC, 
TABLE  III 
Supernatants from Th HA Require Specific Antigen  for Promotion of In Vitro IgA Responses in 
LPS-triggered Splenic B Cell Cultures 
Supernatant source 
Antigen stimulating IgA response (PFC per culture) 
SRBC  HRBC  TNP-SRBC 
Th HAl 
1  359_40(10-+4)  265-+39  (7_+4)  329_+36  (7_+ 3) 
3  488 4- 49(11-+3)  367_+48  (5_+3)  409_+48  (5_+  1) 
4  540_+55  (7 _-4- 2)  398_+57  (6_+2)  512-+83  (7--+3) 
5  490_+61(10+3)  332_+51  (8_+4)  539--+.41  (4+2) 
7  545_+37  (5+  1)  401-30  (7-+3)  498-+31  (10-+2) 
8  604-+91  (6_+2)  423_+72(10_+4)  512_+58  (8_+3) 
9  525_+36  (8_+4)  371_+  19  (7+2)  480+39  (7-+2) 
10  582_+39  (5_+2)  329_+28  (5----.2)  373 -4- 52  (6_+3) 
ThHAgl4  529+32  (6___3)  409+45  (4_+1)  432_+21  (6_+2) 
R I.1  2 _+ 2  (0)  1 +  1  (0)  2 +  2  (0) 
See Table 1 for culture details. Briefly, LPS-triggered B cells (2.5 X 106 cells/well) were incubated 
with SRBC, HRBC, or TNP-SRBC (or without antigen) in the presence of Th HA supernatants, 
and IgA PFC were assayed on day 5 of culture. 
* Values are the mean IgA PFC per culture +SEM from triplicate cultures for each experiment, and 
four separate experiments. Numbers in parenthesis are IgA PFC per culture, without antigen. IgA 
PFC  responses  without  Th HA  supernatants  were:  SRBC  (0-3  cells/culture);  HRBC  (0-2 
cells/culture), and TNP-SRBC (0-4 cells/culture). No polyclonal PFC were induced with specific 
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HRBC,  and  TNP  were  seen  (Table  IV).  However,  identically  treated  splenic  B 
TABLE  IV 
Supernatants from Th HA Support In Vitro IgA Responses in Normal PP B Cell Cultures 
Supernatant source 
Antigen stimulating IgA response (PFC per culture)* 
SRBC  HRBC  TNP-SRBC 
Th HA~ 
1  38I +43(8+4)  206-+29(7-+3)  366-+  t9(6-+  1) 
3  520 -+ 36 (8 -+ 3)  348 -+ 45 (6 -+ 2)  497 -+ 51 (6 -+ 2) 
4  554 -+ 69 (4 +  2)  356 -+ 38 (5 +  4)  501  -+ 23 (9 -+ 3) 
5  483 -+ 47 (9 +  5)  312 -+ 44 (7 -+ 3)  514 -+ 52 (8 -+ 2) 
7  549 +  31  (4 -+ 3)  409 -+ 42 (6 -+ 3)  486 --- 11 (4 -  1) 
8  492 -+ 55 (6 -+ 3)  354 -+ 42 (7 -+ 1)  491  -+ 43 (5 -+ 2) 
9  503 -+ 26 (7 -+ 2)  328 +  26 (5 -+ 2)  398 -+ 40 (6-+ 1) 
10  547 -+ 49 (5 -+ l)  311  -+ 27 (4 -+ 2)  409-+ 28 (5-+  1) 
Th HA9 
14  488 -  37 (6 +  2)  350-+ 26 (3 -+ 2)  421 -+ 36 (4 -  2) 
R I.I  1 -+  1 (0)  0(0)  2-  1  (0) 
pP cells were treated with a  cocktail of anti-Thy-1.2, anti-Lyt-l, and anti-Lyt-2 mAb, plus rabbit 
complement. PP B cells (2.5 x  10  ~) were cultured with SRBC, HRBC, or TNP-SRBC (or without 
antigen) in  the presence of supernatants from  Th HA.  IgA anti-SRBC, -HRBC,  or -TNP  PFC 
responses were assessed on day 5 of culture. 
* Values are the mean lgA PFC per culture _+SEM from triplicate cultures for each experiment, for 
three separate experiments. Numbers in parenthesis are lgA PFC per culture without antigen. IgA 
PFC  responses  without  Th HA  soluble  factors  were:  SRBC  (2-9  cells/culture),  HRBC  (2-5 
cells/culture), and TNP (3-9  cells/culture),  lgG PFC responses with Th HA supernatants were: 
SRBC (0-5 cells/culture), HRBC (0-3 cells/culture), and TNP (0-8 cells/culture). 
TABLE  V 
Supernatants from Th HA Do Not Support Polyclonal Ig Responses 
Supernatant  Source of B cell 
source  cultures 
Total lg synthesis* 
IgM  lgG  IgA 
Th HAl  PP  ng/ml 
5  675  412 
9  702  531 
Th HA9 
14  798  300 
None  813  496 
389 
411 
432 
443 
Th HA1 
5 
9 
Th HA9 
14 
None 
Spleen 
30,022  879  413 
28,435  904  450 
25,751  1,038  404 
31,476  955  434 
PP-  or  LPS-pretreated  splenic  B  cell  cultures  (see  Tables  I  and  IV 
legends) were incubated with supernatants from Th HA for 5 d. 
* Culture  supernatants  were  harvested,  and  total  lgM,  IgG,  or  lgA 
syntheses were measured by radioimmunoassay (see Materials and Meth- 
ods). K|YONO ET  AL.  739 
cell cultures (non-LPS-stimulated)  gave essentially no  IgA responses (data not 
shown).  No IgG PFC responses were noted in immunized  PP B cell cultures in 
the presence of any of the  16 Th HA supernatants.  These results suggest that 
Th HA supernatants contain factor(s) that allow selective triggering of committed 
sIgA + B cells for this isotype response. 
It  could  be  argued  that  Th HA  supernatants  contain  factors  which  induce 
polyclonal  IgA  responses, and  that  this  would not be detected  with  IgA  PFC 
response assays to heteroiogous erythrocytes or to hapten.  Therefore,  in other 
experiments, soluble Th HA factors were added to either normal  PP B cells, or 
LPS-triggered splenic B cells, and IgM, IgG, and IgA synthesis was measured in 
culture  supernatants.  As  can  be seen  in  Table  V,  these  supernatants  did  not 
enhance Ig synthesis in PP B cell cultures over the base line controls (no soluble 
factors  added).  With  splenic  B  cells,  prior  treatment  with  LPS  resulted  in 
significant IgM and some IgG synthesis within 5 d, however, no enhancement of 
IgM  or  IgG  synthesis occurred  in  the  presence  of Th HA  supernatants.  IgA 
synthesis  was  minimal  in  all  cultures  tested  (Table  V).  When  cultures  were 
incubated for 7 d and Ig measured in the culture supernatants,  the pattern of Ig 
synthesis was unchanged (data not shown). We conclude from these experiments 
that Th HA soluble factors do not possess polyclonai B cell activation properties, 
nor do they support polycional IgA synthesis. 
Th HA  Supernatants  Contain  IBF~  That  Regulate  Antigen-dependent  IgA  Re- 
sponses.  Recent studies (16,  17) have shown that T  cell hybridomas that possess 
Fc~xR can be induced  to release  IBFa, presumably the released form of FcaR. 
We have considered the possibility that  the  16 Th HA cell lines synthesize and 
secrete IBFot, which could account for the promotion of IgA responses by these 
supernatants.  To test this,  aliquots of three separate  supernatants  were passed 
over immunoadsorbent  columns (IgA,  IgM,  or IgGl),  and  the effluents (non- 
Ig-bound) and  eluates  were tested separately for promotion  of IgA  responses. 
Passage over the  IgA column  removed the factor(s) which promoted IgA  PFC 
responses from all three supernatants  tested. The  factor(s) could be recovered 
in the eluate, as shown by its ability to support good IgA responses (Fig.  1).  In 
contrast,  passage of supernates over IgM or IgG columns failed to remove the 
active fractions,  clearly indicating  that  the  factor(s) does not bind to these  Ig. 
These results indicate that promotion of IgA responses by Th HA supernatants 
is largely due to the presence of IBFa.  In another experiment,  we have shown 
that  the  eluate  from a  MOPC  315  IgA  column,  when  passed again  over this 
immunoadsorbent,  left no IgA-promoting activity in the effluent. However, full 
activity was recovered in the eluate, and preincubation of the eluate with purified 
IgA,  but  not  F(ab')2  of IgA,  IgM,  or  IgG1,  completely  abrogates  IgA  PFC 
responses (data not shown). 
Purified eluates from four different Th HA supernatants  were tested over a 
wide concentration range for enhancement of IgA responses in SRBC-immunized 
PP  B  cell  cultures.  As can  be seen  in  Fig.  2,  higher  concentrations  of IBFc~ 
resulted in lower IgA responses, dilutions of ~1:10 gave highest IgA responses. 
Three of the four IBF~ gave a  similar dose-response pattern,  while IBFa from 
Th HA]-10  exhibited  somewhat  lower  IgA-enhancement  activity.  Column 
eluates  from  R I.1  supernatants  (Fig.  2),  or  from  non-IgA-enhancing  culture 740  IgA-BINDING  FACTOR  REGULATION  OF  lgA  RESPONSES 
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FIGURE  I.  Detection of IBF wesent in Th HA  supernatants by affinity chromatography. 
Aliquots (35-40 ml) of hybridoma supernatants from Th HAI-9 (1[), -10 (VA), or -I4 (F-I) grown 
in FCS-free HB 102 media were passed over IgA, IgM, or IgG Sepharose 4-B immunoadsor- 
bent columns. The effluents and eluates (see Materials and Methods) were tested separately 
for  their ability  to  support  IgA  anti-SRBC  PFC  responses in  PP  B  cell  cultures.  Control 
cultures (PP B cells with column fractions and no antigen) gave responses ranging from 4 to 
17  IgA PFC per culture. Cultures with SRBC and no column fraction yielded 3-9 lgA PFC 
per culture. 
fractions (data not shown) exhibited no IgA-promoting activity in SRBC-immu- 
nized  B  cell  cultures.  These  results  suggested  that  optimal  concentrations  of 
IBFa are required for in vitro IgA responses, and that higher concentrations are 
suppressive. 
To determine whether IBFa regulates T-dependent responses, PP cell cultures 
from orally SRBC-primed mice were cultured in vitro with SRBC, a procedure 
previously shown to yield good IgA responses (19),  and  the  effect of purified 
IBFa was assessed.  Higher concentrations  of IBFa were suppressive (Fig.  3A), 
while less IBFa enhanced in vitro IgA anti-SRBC PFC responses. Similar results 
were also noted when these concentrations of IBFa were tested in splenic B cell 
cultures containing  PP Th  from orally primed  mice (Fig.  3B),  The pattern  of 
IBFa regulation  was similar in both culture systems, and the two highest  IBFa 
concentrations  suppressed,  while  the  next  three  lower  doses  enhanced  IgA 
responses. 
Discussion 
Studies with cloned T  cells from murine PP or human T  cell hybridomas have 
suggested at least two major mechanisms for T  cell regulation of IgA responses. 
Kawanishi et al. (23, 24) have produced PP T  cell clones which induce sIgM  + B KIYONO  ET  AL.  741 
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F1GUR~  2.  Dose-response  characteristics of  affinity-purified  1BFa. Dilutions of IBFa obtained 
from Th HA1-3 (O), -9 (O), -10 (B), or Th HAg-14  (r-l) were assessed for their ability  to support 
IgA anti-SRBC PFC responses in PP B cell cultures. See Fig. 1 legend and Materials and 
Methods for details. Control fractions of R1.1 lymphoma (A) are as indicated. 
cells to switch to expression of sIgA. The post-switched sIgA  + B cells were only 
induced  to  secrete  IgA  in  the  presence  of B  cell  growth  and  differentiation 
factors (33). This suggested that switch T  cells are major determinants for B cell 
commitment to IgA, and that isotype-specific regulatory T  cells are not required 
for  IgA  synthesis.  Contrary  to  this,  our  studies  with  antigen-induced,  IgA 
isotype-specific clones  of PP Th A  cells  indicate  that  GALT  Th  cells  select 
already committed (sIgA  +) cells from the B cell subpopulation for IgA responses 
(21,22). These PP Th A cells bear FcaR, and may recognize the Fco~  determinant 
on committed, sIgA  + B cells, thus inducing B cell differentiation to IgA synthesis 
through either direct cell contact, or via secreted FcaR. In support of this is the 
finding that  preincubation  of PP Th A  cells with purified  IgA, but not F(ab')2 
of IgA (or of the IgM or IgG subclasses), abrogates IgA-specific responses (30). 
The Fco~R may not represent the only determinant involved in isotype regulation, 
since elegant studies by Mayer and  coworkers (34) have shown that  human  T 
cell  hybridomas  express  mainly  Fc#R,  but  secrete  factor(s)  that  support  IgA 
responses.  It is interesting  that  maximum  IgA responses occurred with B cells 
already committed to the IgA isotype, and implied that non-IgA-binding factors 
or a-lymphokines may also regulate IgA responses. 
To  determine  the  molecular  basis  for  IgA  response  regulation,  we  have 
produced T-T  hybridomas (Th HA cells) from two well-characterized PP Th A 
clones (1  and 9).  Th HA culture supernatants  did not induce IgA responses in 
normal splenic B cell cultures immunized with T-dependent antigens,  however, 
prior stimulation  of B cells with  LPS (18 h) followed by immunization  with T- 
dependent  antigen  in  the  presence  of Th HA  soluble factors  resulted  in  IgA 
responses. Certain Th HA supernatants also supported small, antigen-dependent 
IgG  responses  (Table  I).  The  reason  for  the  IgG  response  is  not  yet  clear, 742  lgA-BINDING  FACTOR  REGULATION  OF  lgA  RESPONSES 
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FIGURE  -'].  IBFa  regulation  of T-dependent  IgA  anti-SRBC  PFC  responses.  Dilutions of 
purified 1BFa from Th HAl-9 (O) or -10 (I) were assessed for suppression or enhancement of 
IgA  responses in  either (A) whole  PP  cell  cultures from  ovally  SRBC-primed mice or  (B) 
splenic B cell cultures containing PP Th cells and SRBC. The horizontal dashed line indicates 
the level of IgA anti-SRBC response in the absence of IBFc~. 
however, it is known that LPS triggers IgM and certain IgG-subclass polyclonal 
responses (35).  It is  possible  that  LPS  triggers clones of IgG  subclasses, and, 
together with T-dependent antigen, would result in specific IgG PFC responses. 
This explanation was borne out by our finding that Th HA supernatants did not 
promote significant IgG responses in normal PP B cell cultures, although  IgA 
responses were clearly enhanced (Table IV).  Thus,  we have no evidence that 
Th HA supernatants contain IgG-enhancing factors, although additional studies 
will be required to firmly establish this point. 
Each  Th HA  cell  line  which secreted factor(s) that  supported  in  vitro  IgA 
responses to T-dependent antigen was shown to express Fc0tR (Table II). This 
finding raised the possibility that released FeaR, or IBF0~, may account for the 
ability of Th HA culture supernatants to support IgA responses. This suggestion 
was verified by experiments which showed that the factors which promoted IgA 
responses  were selectively removed by  IgA (but not by  IgM  or  IgG) affinity 
columns (Fig.  1).  Furthermore, elution of the IBF~ from the column allowed KIYONO ET AL.  743 
recovery of biologically active components,  which,  when added  to  PP  B  cell 
cultures, supported IgA-isotype responses. Interestingly, the most concentrated 
IBFo~ supported less IgA response, while diluted (1:10) samples gave maximum 
support (Fig. 2). It is possible that excessive amounts of IBFoL may bind to slgA  ÷ 
B cells and actually inhibit isotype responses. 
Recently, others  (16,  17)  have  characterized released  Fco~R from a  T  cell 
hybridoma line,  T2D4,  which simultaneously expresses both  Fc~,R  and  Fc~R. 
When T2D4 cells were incubated at 37°C with purified mouse IgA in medium 
containing FCS,  the Fc~R was selectively released (16).  In other studies, they 
showed that Con A-stimulated spleen cells, when incubated with IgA, released 
I BF~ into the culture supernatant (17). Purification of these I BFa by IgA affinity 
chromatography yielded molecules capable of suppressing pokeweed mitogen- 
driven polyclonal IgA responses (16,  17).  When FcTR  ÷ T  cells were removed 
from Con A-stimulated cultures, production of IBF0t was eliminated, suggesting 
that IBFa-releasing cells are also Fc3,R + (17).  This is consistent with the simul- 
taneou  s expression of Fc3,R and FcaR on the T~D4 T  cell line, and suggests that 
T  cells first express FcTR before they express Fc~R (17).  In this  regard, it is 
possible that T  ceils may first express either Fc#R or Fc3,R before induction (by 
IgA) of the FcaR. One might speculate that the hybridomas described by Mayer 
et al. (34) express mainly Fc#R, but that they may produce factors which bind 
IgA, and support  IgA responses in cultures containing cells committed to this 
isotype. 
Others (9-12,  36-41)  have extensively characterized potentiating and  sup- 
pressing IBF~ produced by rat Fc~R  ÷ T  cells that acted on slgE  ÷ committed B 
cells to regulate isotype-specific immune responses. The IgE-potentiating factor 
binds  IgE,  is  ~15,000  mol  wt,  and  possesses  a  mannose-rich oligosaccharide 
responsible for binding to  lentil lectin and Con A  (9,  10,  12,  36-38,  40,  41). 
The IgE-suppressive factor is of similar molecular weight, also binds  IgE, but 
lacks the mannose-rich polysaccharide moiety (9,  11,  12,  37-39,  41).  Recent 
studies (42, 43) in mice suggest that similar IBFc regulate murine IgE responses. 
The  IBFo~ produced  by  Th HA  cell  lines  reported  here  support  antigen- 
dependent IgA responses, in contrast to the IBFot (16,  17) and IBF~ (9--12, 36- 
43) described above, which regulate the global isotype-specific response. Thus, 
both T-dependent antigen and IBFa are required for IgA responses. However, 
the addition of IBFa to cultured B cells, alone or with antigen, did not induce 
polyclonal IgA synthesis (Table V).  Furthermore, an optimal amount of IBFa 
was required for promotion of IgA responses; higher concentrations were sup- 
pressive (Fig. 2), a point considered in more detail below. Thus, a dual triggering 
event is required, i.e., binding of antigen to specific clones of sIgA  + B cells, and 
a second signal, provided by binding IBFa to the Fc of membrane IgA. When 
both  signals are produced, the committed B  cell is activated, and induced to 
differentiate into cells that synthesize specific IgA. Th HA supernatants may also 
contain B cell differentiation factors. However, it is clear that the IgA-promoting 
factors bind IgA, and it would be necessary to postulate the existence of a B cell 
differentiation factor specific for IgA. If it can be shown that IBFa binds to the 
Fc of membrane IgA, and (in the presence of antigen) triggers final differentia- 
tion  to plasma cells synthesizing IgA, then  it would be appropriate  to classify 744  IgA-BINDING FACTOR  REGULATION OF  lgA  RESPONSES 
these IBFa molecules as IgA-specific B cell differentiation factors. In this regard, 
we are currently characterizing these IBFa  for molecular size,  heterogeneity, 
and protein and glycoprotein content, the results of which will be the subject of 
a future paper. 
To  date,  IBF~  has  been  obtained  that  exhibits  two  apparently  different 
functions. Our studies show that IBFot promotes specific IgA responses to various 
T-dependent antigens, and does not induce polyclonal IgA responses.  Higher 
concentrations of IBFc~ suppress in  vitro  IgA responses,  while lesser amounts 
enhance this isotype response (Fig.  3). Other studies (16,  17), described above, 
suggest  that  released  FcctR,  or  IBFct,  can  suppress  polyclonal IgA  responses. 
Two explanations may be given for these apparent differences. The first is that 
only one class of IBFa is produced, and depending upon its concentration and 
the experimental conditions employed for bioassay, it could either promote or 
suppress  IgA responses.  Thus,  in  our assays,  LPS-triggered splenic B  cells or 
normal  PP  B  cell  cultures (with high  frequencies of sIgA  + B  cells),  help,  or, 
enhancement by IBFa is seen. Furthermore, higher concentrations of IBFa, in 
cultures containing isotype-specific Th  cells and IgA  B cell precursors, down- 
regulate the IgA response. This may explain the results of others (16,  17), which 
show that released FcaR suppressed pokeweed mitogen-driven polyclonal IgA 
responses. The second possibility is that, like the IBFe-regulated IgE system, two 
classes of IBFa are produced, one of which promotes, and the second of which 
suppresses  IgA responses.  Our Th HA cells may produce less  suppressive fac- 
tor(s),  thus,  a  high  concentration was  required  for  the  observed effect. The 
major product of these cell lines would be a helper form of IBFa that enhances 
antigen-dependent IgA responses. In the other studies described above (16,  17), 
the T2D4 hybridoma, or Con A-stimulated T  cells may produce mainly suppres- 
sive forms of IBFoe. We are currently purifying the IBF0~ produced by different 
Th HA cell lines to homogeneity, to help resolve this important issue. 
Summary 
T-T hybridomas, produced by fusions between R 1.1 T  lymphoma and cloned 
T  helper cells that promote IgA responses (Th A cells) were characterized in this 
study. A total of 85 cloned cell lines were produced, and their supernatants were 
assessed for support of antigen-dependent IgA (and IgM and IgG) responses.  16 
of 85  culture  fractions supported  IgA anti-sheep  red blood  cell,  -horse red 
blood cell,  or -trinitrophenyl responses in  either lipopolysaccharide-triggered 
splenic B cell, or normal Peyer's patch B cell cultures, and the responses were 
specific for the antigen used for in vitro immunization. None of the supernatants 
from the cell lines induced significant polyclonal responses in these B cell cultures. 
Interestingly, the 16 hybridomas that produced supernatants with IgA-promot- 
ing properties had Fc receptors for IgA (FcotR),  but did not express Fc~tR or 
FcTR. When supernatants from FcctR  + T  cell lines were subjected to IgA affinity 
chromatography,  the  IgA-promoting activity  bound  to  IgA  (IBFa)  and  was 
recovered in the eluate. No binding of active fractions occurred when supernates 
were passed through IgM or IgG immunoadsorbent columns. High concentra- 
tions of purified IBFa suppressed T-dependent IgA responses, while an optimal 
level was required for enhancement of this isotype response. These results suggest K|YONO  ET  AL.  745 
that  Fcc~R + hybridomas derived  from Th A  cells release  IBFc~  into  the  culture 
medium, and that these molecules regulate IgA responses to various T-dependent 
antigens. 
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